Phase 1: Ceralasertib, Durvalumab in NSCLC and HNSCC
In a groundbreaking stride towards combating some of the deadliest forms of cancer, researchers have unveiled promising early results from a Phase 1 clinical trial exploring the novel therapeutic combination of...
Read moreDetails





















